Study of Human Botulism Immunoglobulin in Infants With Botulism

Completed · Not applicable

Conditions studied: Infant Botulism, Botulism

In brief

OBJECTIVES: I. Determine the safety of human botulism immune globulin (BIG) in patients with infant botulism by monitoring side effects (e.g., rash, fever, hypotension, and anaphylaxis). II. Assess the efficacy of BIG in these patients by monitoring disease severity, incidence of complications (respiratory arrest, aspiration, pneumonia, etc.), and length of hospital stay.

Key facts

Study ID

NCT00004401

Run by

California Department of Health Services

People needed

120

Starts

1998-01-01

Expected to finish

1998-06-01

Last updated by the study team

2015-03-25

Who can join

Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.

Where it is running

• California Department of Health Services — Berkeley, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.